Skip to main content

Mouse Monoclonal PD-L1 antibody. Suitable for IHC-P, Flow Cyt, WB and reacts with Human samples. Cited in 30 publications. Immunogen corresponding to Recombinant Fragment Protein within Human CD274 aa 1-250.


Images

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [ABM4E54] (AB210931), expandable thumbnail
  • Flow Cytometry - Anti-PD-L1 antibody [ABM4E54] (AB210931), expandable thumbnail
  • Western blot - Anti-PD-L1 antibody [ABM4E54] (AB210931), expandable thumbnail
  • Western blot - Anti-PD-L1 antibody [ABM4E54] (AB210931), expandable thumbnail

Publications

Key facts

Isotype
IgG2a
Host species
Mouse
Storage buffer

Preservative: 0.05% Sodium azide
Constituents: 99% PBS, 0.05% BSA

Form
Liquid
Clonality
Monoclonal

Immunogen

  • Recombinant Fragment Protein within Human CD274 aa 1-250. The exact immunogen used to generate this antibody is proprietary information. Database link Q9NZQ7

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
IHC-PFlow CytWB
Human
Tested
Tested
Tested

Tested
Tested

Species
Human
Dilution info
5 µg/mL
Notes

Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.

Tested
Tested

Species
Human
Dilution info
1.00000-2.00000 µg/mL
Notes

-

Tested
Tested

Species
Human
Dilution info
0.5 µg/mL
Notes

-

Associated Products

Select an associated product type

8 products for Alternative Product

Target data

Function

Plays a critical role in induction and maintenance of immune tolerance to self (PubMed:11015443, PubMed:28813410, PubMed:28813417, PubMed:31399419). As a ligand for the inhibitory receptor PDCD1/PD-1, modulates the activation threshold of T-cells and limits T-cell effector response (PubMed:11015443, PubMed:28813410, PubMed:28813417, PubMed:36727298). Through a yet unknown activating receptor, may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (PubMed:10581077). Can also act as a transcription coactivator: in response to hypoxia, translocates into the nucleus via its interaction with phosphorylated STAT3 and promotes transcription of GSDMC, leading to pyroptosis (PubMed:32929201). The PDCD1-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and escape destruction by the immune system, thereby facilitating tumor survival (PubMed:28813410, PubMed:28813417). The interaction with PDCD1/PD-1 inhibits cytotoxic T lymphocytes (CTLs) effector function (By similarity). The blockage of the PDCD1-mediated pathway results in the reversal of the exhausted T-cell phenotype and the normalization of the anti-tumor response, providing a rationale for cancer immunotherapy (By similarity).

Alternative names

Recommended products

Mouse Monoclonal PD-L1 antibody. Suitable for IHC-P, Flow Cyt, WB and reacts with Human samples. Cited in 30 publications. Immunogen corresponding to Recombinant Fragment Protein within Human CD274 aa 1-250.

Key facts

Isotype
IgG2a
Form
Liquid
Clonality
Monoclonal
Immunogen
  • Recombinant Fragment Protein within Human CD274 aa 1-250. The exact immunogen used to generate this antibody is proprietary information. Database link Q9NZQ7
Clone number
ABM4E54
Purification technique
Affinity purification Protein G
Light chain type
kappa
Concentration
Loading...

Storage

Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Notes

Abcam is leading the way to address reproducibility in scientific research with our highly validated recombinant monoclonal and recombinant multiclonal antibodies. Search & select one of Abcam's thousands of recombinant alternatives to eliminate batch-variability and unnecessary animal use.

If you do not find a host species to meet your needs, our catalogue and custom Chimeric range provides scientists the specificity of Abcam's RabMAbs in the species backbone of your choice. Remember to also review our range of edited cell lines, proteins and biochemicals relevant to your target that may help you further your research goals.

Abcam antibodies are extensively validated in a wide range of species and applications, so please check the reagent specifications meet your scientific needs before purchasing. If you have any questions or bespoke requirements, simply visit the Contact Us page to send us an inquiry or contact our Support Team ahead of purchase.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

PD-L1 also known as Programmed Death-Ligand 1 or CD274 is a protein involved in immune modulation. Mechanically PD-L1 interacts with its receptors particularly PD-1 to regulate cellular immune responses. This transmembrane protein has a calculated molecular weight of approximately 33 kDa. PD-L1 is expressed on various cell types including tumor cells and immune cells such as dendritic cells macrophages and B cells. Its expression is often upregulated in response to inflammatory cytokines.

Biological function summary

PD-L1 plays a central role in immune evasion mechanisms utilized by tumors. It is not part of a larger protein complex but directly interacts with PD-1 and CD80. When PD-L1 binds to PD-1 it sends inhibitory signals leading to decreased T cell activation and proliferation allowing cancer cells to avoid immune destruction. PD-L1 expression provides a mechanism for tumors to suppress immune surveillance facilitating tumor progression.

Pathways

PD-L1 is integral to the immune checkpoint pathway which is an important regulator of immune response. The interaction between PD-L1 and PD-1 provides a mechanism for immune tolerance which is part of the broader adaptive immune system pathway. PD-L1 is related to other immune checkpoint proteins such as CTLA-4 in its function to limit autoreactivity and promote immune homeostasis.

Associated diseases and disorders

PD-L1 is most associated with cancer particularly in tumors such as melanoma and non-small cell lung cancer. PD-L1 expression on tumor cells often correlates with poor prognosis. PD-L1 directly interacts with PD-1 in these cancers a target for immunotherapies such as checkpoint inhibitors which aim to block this interaction and restore immune activity against tumors. PD-L1 involvement extends to autoimmune disorders where altered expression can impact tolerance and lead to immune-related tissue damage.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

4 product images

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [ABM4E54] (ab210931), expandable thumbnail

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [ABM4E54] (ab210931)

    Immunohistochemical analysis of formalin-fixed paraffin-embedded Human Hodkin's lymphoma tissue, labeling PD-L1 with ab210931at 5 μg/mL.

  • Flow Cytometry - Anti-PD-L1 antibody [ABM4E54] (ab210931), expandable thumbnail

    Flow Cytometry - Anti-PD-L1 antibody [ABM4E54] (ab210931)

    Cell Surface flow cytometry analysis of PD-L1 in PHA treated human PBMC using 1 μg of ab210931. Green represents isotype control; pink represents ab210931 antibody. Goat anti-mouse PE conjugate was used as secondary antibody.

  • Western blot - Anti-PD-L1 antibody [ABM4E54] (ab210931), expandable thumbnail

    Western blot - Anti-PD-L1 antibody [ABM4E54] (ab210931)

    All lanes: Western blot - Anti-PD-L1 antibody [ABM4E54] (ab210931) at 0.5 µg/mL

    All lanes: Recombinant protein fragment of Human PD-L1

    Predicted band size: 33 kDa

  • Western blot - Anti-PD-L1 antibody [ABM4E54] (ab210931), expandable thumbnail

    Western blot - Anti-PD-L1 antibody [ABM4E54] (ab210931)

    Exposure time: 1 minute in film and 30 seconds in imager.

    All lanes: Western blot - Anti-PD-L1 antibody [ABM4E54] (ab210931) at 2 µg/mL

    Lane 1: A549 lysate at 30 µg

    Lane 2: MCF-7 lysate at 30 µg

    Lane 3: 293 lysate at 30 µg

    Lane 4: HCT-116 lysate at 30 µg

    Lane 5: Saos2 lysate at 30 µg

    Lane 6: HeLa lysate at 30 µg

    Predicted band size: 33 kDa

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com